These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 34239333)
1. Understanding and Managing Corticosteroid-Induced Osteoporosis. Kobza AO; Herman D; Papaioannou A; Lau AN; Adachi JD Open Access Rheumatol; 2021; 13():177-190. PubMed ID: 34239333 [TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options. De Nijs RN Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694 [TBL] [Abstract][Full Text] [Related]
3. Secondary osteoporosis: underlying disease and the risk for glucocorticoid-induced osteoporosis. Boling EP Clin Ther; 2004 Jan; 26(1):1-14. PubMed ID: 14996513 [TBL] [Abstract][Full Text] [Related]
4. Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. Weinstein RS; Chen JR; Powers CC; Stewart SA; Landes RD; Bellido T; Jilka RL; Parfitt AM; Manolagas SC J Clin Invest; 2002 Apr; 109(8):1041-8. PubMed ID: 11956241 [TBL] [Abstract][Full Text] [Related]
5. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699 [TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment. Chotiyarnwong P; McCloskey EV Nat Rev Endocrinol; 2020 Aug; 16(8):437-447. PubMed ID: 32286516 [TBL] [Abstract][Full Text] [Related]
12. Patient satisfaction and efficacy of switching from weekly bisphosphonates to monthly minodronate for treatment and prevention of glucocorticoid-induced osteoporosis in Japanese patients with systemic rheumatic diseases: a randomized, clinical trial. Tamechika SY; Sasaki K; Hayami Y; Ohmura SI; Maeda S; Iwagaitsu S; Naniwa T Arch Osteoporos; 2018 Jun; 13(1):67. PubMed ID: 29904824 [TBL] [Abstract][Full Text] [Related]
14. [Glucocorticoid-induced osteoporosis]. Tóth M; Tulassay Z Orv Hetil; 2000 Jan; 141(5):219-23. PubMed ID: 10697979 [TBL] [Abstract][Full Text] [Related]
15. Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report. Levis S; Theodore G J Manag Care Pharm; 2012 May; 18(4 Suppl B):S1-15; discussion S13. PubMed ID: 22716221 [TBL] [Abstract][Full Text] [Related]
17. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic strategy for glucocorticoid-induced osteoporosis]. Hayakawa N; Suzuki A Clin Calcium; 2013 Sep; 23(9):1337-44. PubMed ID: 23999371 [TBL] [Abstract][Full Text] [Related]